avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hic2
|
ENSMUSG00000050240.17 | Hic2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hic2 | mm39_v1_chr16_+_17051423_17051528 | -0.54 | 7.0e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_140343652 | 4.92 |
ENSMUST00000026552.9
ENSMUST00000209253.2 ENSMUST00000210235.2 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr19_-_46661321 | 4.17 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr16_-_17906886 | 3.99 |
ENSMUST00000132241.2
ENSMUST00000139861.2 ENSMUST00000003620.13 |
Prodh
|
proline dehydrogenase |
chr6_+_121323577 | 3.27 |
ENSMUST00000032200.16
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr6_-_5193816 | 3.13 |
ENSMUST00000002663.12
|
Pon1
|
paraoxonase 1 |
chr11_-_94932158 | 3.05 |
ENSMUST00000038431.8
|
Pdk2
|
pyruvate dehydrogenase kinase, isoenzyme 2 |
chr6_-_5193757 | 2.96 |
ENSMUST00000177159.9
ENSMUST00000176945.2 |
Pon1
|
paraoxonase 1 |
chr19_+_30210320 | 2.96 |
ENSMUST00000025797.7
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr19_+_20579322 | 2.89 |
ENSMUST00000087638.4
|
Aldh1a1
|
aldehyde dehydrogenase family 1, subfamily A1 |
chr19_+_7034149 | 2.88 |
ENSMUST00000040261.7
|
Macrod1
|
mono-ADP ribosylhydrolase 1 |
chr12_-_103925197 | 2.86 |
ENSMUST00000122229.8
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr7_+_26006594 | 2.76 |
ENSMUST00000098657.5
|
Cyp2a4
|
cytochrome P450, family 2, subfamily a, polypeptide 4 |
chr4_+_115375461 | 2.67 |
ENSMUST00000058785.10
ENSMUST00000094886.4 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr1_+_74371755 | 2.66 |
ENSMUST00000087225.6
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr6_+_124547247 | 2.60 |
ENSMUST00000184647.2
|
C1rb
|
complement component 1, r subcomponent B |
chr13_-_63036096 | 2.55 |
ENSMUST00000092888.11
|
Fbp1
|
fructose bisphosphatase 1 |
chr7_-_105249308 | 2.52 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr7_+_26534730 | 2.48 |
ENSMUST00000005685.15
|
Cyp2a5
|
cytochrome P450, family 2, subfamily a, polypeptide 5 |
chr1_+_133291302 | 2.34 |
ENSMUST00000135222.9
|
Etnk2
|
ethanolamine kinase 2 |
chr7_-_12731594 | 2.31 |
ENSMUST00000133977.3
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr12_-_103739847 | 2.27 |
ENSMUST00000078869.6
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chr19_-_46661501 | 2.15 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr11_-_59927688 | 2.14 |
ENSMUST00000102692.10
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr6_-_136852792 | 2.05 |
ENSMUST00000032342.3
|
Mgp
|
matrix Gla protein |
chr6_+_121320008 | 2.04 |
ENSMUST00000166457.8
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr11_-_43727071 | 2.03 |
ENSMUST00000167574.2
|
Adra1b
|
adrenergic receptor, alpha 1b |
chr1_+_93062962 | 2.02 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr19_-_42117420 | 1.98 |
ENSMUST00000161873.2
ENSMUST00000018965.4 |
Avpi1
|
arginine vasopressin-induced 1 |
chr2_+_155359868 | 1.98 |
ENSMUST00000029135.15
ENSMUST00000065973.9 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr19_-_6918796 | 1.97 |
ENSMUST00000025909.11
ENSMUST00000099774.10 |
Gpr137
|
G protein-coupled receptor 137 |
chr1_-_134163102 | 1.97 |
ENSMUST00000187631.2
ENSMUST00000038191.8 ENSMUST00000086465.6 |
Adora1
|
adenosine A1 receptor |
chr4_-_129121676 | 1.83 |
ENSMUST00000106051.8
|
C77080
|
expressed sequence C77080 |
chr15_-_78352801 | 1.83 |
ENSMUST00000229124.2
ENSMUST00000230226.2 ENSMUST00000017086.5 |
Tmprss6
|
transmembrane serine protease 6 |
chr14_+_21102642 | 1.82 |
ENSMUST00000045376.11
|
Adk
|
adenosine kinase |
chrX_-_8059597 | 1.80 |
ENSMUST00000143223.2
ENSMUST00000033509.15 |
Ebp
|
phenylalkylamine Ca2+ antagonist (emopamil) binding protein |
chr17_+_27236961 | 1.78 |
ENSMUST00000142141.3
ENSMUST00000122106.9 |
Ggnbp1
|
gametogenetin binding protein 1 |
chr5_+_135916764 | 1.74 |
ENSMUST00000005077.7
|
Hspb1
|
heat shock protein 1 |
chr12_-_103923145 | 1.74 |
ENSMUST00000085054.5
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr17_-_31363245 | 1.73 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr8_+_95564949 | 1.72 |
ENSMUST00000034234.15
ENSMUST00000159871.4 |
Coq9
|
coenzyme Q9 |
chr1_+_171238873 | 1.72 |
ENSMUST00000159207.8
ENSMUST00000161241.8 |
Usf1
|
upstream transcription factor 1 |
chr7_-_99340830 | 1.72 |
ENSMUST00000208713.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr12_-_103704417 | 1.71 |
ENSMUST00000095450.11
ENSMUST00000187220.2 |
Serpina1b
|
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
chr8_-_71834543 | 1.71 |
ENSMUST00000002466.9
|
Nr2f6
|
nuclear receptor subfamily 2, group F, member 6 |
chr15_-_76193955 | 1.71 |
ENSMUST00000210024.2
|
Oplah
|
5-oxoprolinase (ATP-hydrolysing) |
chr3_+_89136353 | 1.70 |
ENSMUST00000041142.4
|
Muc1
|
mucin 1, transmembrane |
chr5_+_146016064 | 1.68 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr2_-_25390625 | 1.67 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr9_-_21913833 | 1.67 |
ENSMUST00000115336.10
|
Odad3
|
outer dynein arm docking complex subunit 3 |
chr2_-_168583670 | 1.66 |
ENSMUST00000029060.11
|
Atp9a
|
ATPase, class II, type 9A |
chr8_-_106670014 | 1.66 |
ENSMUST00000038896.8
|
Lcat
|
lecithin cholesterol acyltransferase |
chr5_-_116560916 | 1.65 |
ENSMUST00000036991.5
|
Hspb8
|
heat shock protein 8 |
chr7_-_4792530 | 1.65 |
ENSMUST00000168578.3
|
Tmem238
|
transmembrane protein 238 |
chr1_+_171238911 | 1.65 |
ENSMUST00000160486.8
|
Usf1
|
upstream transcription factor 1 |
chr17_-_35081129 | 1.64 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr17_+_37253802 | 1.64 |
ENSMUST00000040498.12
|
Rnf39
|
ring finger protein 39 |
chr2_+_29692638 | 1.64 |
ENSMUST00000080065.3
|
Slc27a4
|
solute carrier family 27 (fatty acid transporter), member 4 |
chr11_+_78389913 | 1.62 |
ENSMUST00000017488.5
|
Vtn
|
vitronectin |
chrX_+_160500623 | 1.61 |
ENSMUST00000061514.8
|
Rai2
|
retinoic acid induced 2 |
chr17_-_46956920 | 1.58 |
ENSMUST00000233974.2
|
Klc4
|
kinesin light chain 4 |
chr2_-_27137272 | 1.58 |
ENSMUST00000102886.10
ENSMUST00000129975.2 |
Sardh
|
sarcosine dehydrogenase |
chr7_-_12732067 | 1.57 |
ENSMUST00000032539.14
ENSMUST00000120903.8 |
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr9_-_21913896 | 1.57 |
ENSMUST00000044926.6
|
Odad3
|
outer dynein arm docking complex subunit 3 |
chr5_+_135916847 | 1.54 |
ENSMUST00000111155.2
|
Hspb1
|
heat shock protein 1 |
chr9_-_100916910 | 1.53 |
ENSMUST00000142676.8
ENSMUST00000149322.8 ENSMUST00000189498.2 |
Pccb
|
propionyl Coenzyme A carboxylase, beta polypeptide |
chr3_+_107538638 | 1.51 |
ENSMUST00000106703.2
|
Gm10961
|
predicted gene 10961 |
chr6_+_113460258 | 1.51 |
ENSMUST00000032422.6
|
Creld1
|
cysteine-rich with EGF-like domains 1 |
chr16_+_22713593 | 1.48 |
ENSMUST00000232674.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr7_-_140462221 | 1.46 |
ENSMUST00000026559.14
|
Sirt3
|
sirtuin 3 |
chr7_-_30752547 | 1.42 |
ENSMUST00000206030.2
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr17_-_57529827 | 1.42 |
ENSMUST00000177425.2
|
C3
|
complement component 3 |
chr11_+_104122216 | 1.41 |
ENSMUST00000106992.10
|
Mapt
|
microtubule-associated protein tau |
chr11_+_90140294 | 1.41 |
ENSMUST00000004050.7
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr2_-_32321116 | 1.40 |
ENSMUST00000127961.3
ENSMUST00000136361.8 ENSMUST00000052119.14 |
Slc25a25
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
chr7_+_44499374 | 1.40 |
ENSMUST00000141311.8
ENSMUST00000107880.9 ENSMUST00000208384.2 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chrX_+_100427331 | 1.40 |
ENSMUST00000119190.2
|
Gjb1
|
gap junction protein, beta 1 |
chr2_+_119181703 | 1.40 |
ENSMUST00000028780.4
|
Chac1
|
ChaC, cation transport regulator 1 |
chr7_+_67925718 | 1.39 |
ENSMUST00000210558.2
|
Fam169b
|
family with sequence similarity 169, member B |
chr9_-_86577940 | 1.38 |
ENSMUST00000034989.15
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr10_+_128030315 | 1.38 |
ENSMUST00000044776.13
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr4_+_155045372 | 1.38 |
ENSMUST00000049621.7
|
Hes5
|
hes family bHLH transcription factor 5 |
chr8_-_71990085 | 1.37 |
ENSMUST00000051672.9
|
Bst2
|
bone marrow stromal cell antigen 2 |
chr12_+_8971603 | 1.36 |
ENSMUST00000020909.4
|
Laptm4a
|
lysosomal-associated protein transmembrane 4A |
chr12_-_104010690 | 1.36 |
ENSMUST00000043915.4
|
Serpina12
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
chr14_+_21102662 | 1.36 |
ENSMUST00000223915.2
|
Adk
|
adenosine kinase |
chr13_-_93810808 | 1.35 |
ENSMUST00000015941.8
|
Bhmt2
|
betaine-homocysteine methyltransferase 2 |
chr10_+_93324624 | 1.34 |
ENSMUST00000129421.8
|
Hal
|
histidine ammonia lyase |
chr9_-_100916946 | 1.34 |
ENSMUST00000035116.12
|
Pccb
|
propionyl Coenzyme A carboxylase, beta polypeptide |
chr14_+_36776775 | 1.33 |
ENSMUST00000120052.2
|
Lrit1
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 |
chr10_+_80165961 | 1.33 |
ENSMUST00000186864.7
ENSMUST00000040081.7 |
Reep6
|
receptor accessory protein 6 |
chr1_+_166081755 | 1.32 |
ENSMUST00000194964.6
ENSMUST00000192638.6 ENSMUST00000192426.6 ENSMUST00000195557.6 ENSMUST00000192732.6 ENSMUST00000193860.2 |
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr11_-_94492688 | 1.30 |
ENSMUST00000103164.4
|
Acsf2
|
acyl-CoA synthetase family member 2 |
chr4_+_141473983 | 1.29 |
ENSMUST00000038161.5
|
Agmat
|
agmatine ureohydrolase (agmatinase) |
chr11_-_120618052 | 1.29 |
ENSMUST00000106148.10
ENSMUST00000026144.5 |
Dcxr
|
dicarbonyl L-xylulose reductase |
chr5_-_137919873 | 1.29 |
ENSMUST00000031741.8
|
Cyp3a13
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
chr15_-_3612628 | 1.29 |
ENSMUST00000110698.9
|
Ghr
|
growth hormone receptor |
chr6_-_86503178 | 1.27 |
ENSMUST00000053015.7
|
Pcbp1
|
poly(rC) binding protein 1 |
chr19_-_6887361 | 1.27 |
ENSMUST00000025904.12
|
Prdx5
|
peroxiredoxin 5 |
chr12_-_102671154 | 1.27 |
ENSMUST00000178697.2
ENSMUST00000046518.12 |
Itpk1
|
inositol 1,3,4-triphosphate 5/6 kinase |
chr3_-_95811993 | 1.25 |
ENSMUST00000147962.3
ENSMUST00000036181.15 |
Car14
|
carbonic anhydrase 14 |
chr5_+_35198853 | 1.25 |
ENSMUST00000030985.10
ENSMUST00000202573.2 |
Hgfac
|
hepatocyte growth factor activator |
chr19_-_10079091 | 1.24 |
ENSMUST00000025567.9
|
Fads2
|
fatty acid desaturase 2 |
chr6_+_125298372 | 1.23 |
ENSMUST00000176442.8
ENSMUST00000177329.2 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr7_-_79882313 | 1.22 |
ENSMUST00000206084.2
ENSMUST00000205996.2 ENSMUST00000071457.12 |
Cib1
|
calcium and integrin binding 1 (calmyrin) |
chr15_+_99615396 | 1.22 |
ENSMUST00000023760.13
ENSMUST00000162194.2 |
Gpd1
|
glycerol-3-phosphate dehydrogenase 1 (soluble) |
chr11_+_70104736 | 1.21 |
ENSMUST00000171032.8
|
Slc16a11
|
solute carrier family 16 (monocarboxylic acid transporters), member 11 |
chr10_+_128769642 | 1.21 |
ENSMUST00000099112.4
ENSMUST00000218290.2 |
Itga7
|
integrin alpha 7 |
chr7_+_123061535 | 1.20 |
ENSMUST00000098056.6
|
Aqp8
|
aquaporin 8 |
chr7_+_123061497 | 1.20 |
ENSMUST00000033023.10
|
Aqp8
|
aquaporin 8 |
chr1_+_74324089 | 1.18 |
ENSMUST00000113805.8
ENSMUST00000027370.13 ENSMUST00000087226.11 |
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr9_-_65330231 | 1.17 |
ENSMUST00000065894.7
|
Slc51b
|
solute carrier family 51, beta subunit |
chr5_-_31453206 | 1.15 |
ENSMUST00000041266.11
ENSMUST00000172435.8 ENSMUST00000201417.2 |
Fndc4
|
fibronectin type III domain containing 4 |
chr12_-_86931529 | 1.15 |
ENSMUST00000038422.8
|
Irf2bpl
|
interferon regulatory factor 2 binding protein-like |
chr13_+_58956495 | 1.15 |
ENSMUST00000225950.2
ENSMUST00000225583.2 |
Ntrk2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr10_+_128030500 | 1.15 |
ENSMUST00000123291.2
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr7_+_28937898 | 1.15 |
ENSMUST00000138128.3
ENSMUST00000142519.3 |
Yif1b
|
Yip1 interacting factor homolog B (S. cerevisiae) |
chr3_-_101511971 | 1.14 |
ENSMUST00000036493.8
|
Atp1a1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
chr17_-_34250474 | 1.14 |
ENSMUST00000171872.3
ENSMUST00000025186.16 |
Slc39a7
|
solute carrier family 39 (zinc transporter), member 7 |
chr7_-_127307898 | 1.13 |
ENSMUST00000207019.2
|
Bcl7c
|
B cell CLL/lymphoma 7C |
chr6_+_83031502 | 1.13 |
ENSMUST00000092618.9
|
Aup1
|
ancient ubiquitous protein 1 |
chr7_-_25098122 | 1.13 |
ENSMUST00000105177.3
ENSMUST00000149349.2 |
Lipe
|
lipase, hormone sensitive |
chr15_-_3612078 | 1.12 |
ENSMUST00000161770.2
|
Ghr
|
growth hormone receptor |
chr7_+_28240262 | 1.12 |
ENSMUST00000119180.4
|
Sycn
|
syncollin |
chr7_+_28937859 | 1.12 |
ENSMUST00000108237.2
|
Yif1b
|
Yip1 interacting factor homolog B (S. cerevisiae) |
chr8_+_121395047 | 1.11 |
ENSMUST00000181795.2
|
Cox4i1
|
cytochrome c oxidase subunit 4I1 |
chr2_+_34764408 | 1.11 |
ENSMUST00000113068.9
ENSMUST00000047447.13 |
Cutal
|
cutA divalent cation tolerance homolog-like |
chr11_+_75084609 | 1.10 |
ENSMUST00000102514.4
|
Rtn4rl1
|
reticulon 4 receptor-like 1 |
chr13_+_93810911 | 1.10 |
ENSMUST00000048001.8
|
Dmgdh
|
dimethylglycine dehydrogenase precursor |
chr4_+_135870808 | 1.10 |
ENSMUST00000008016.3
|
Id3
|
inhibitor of DNA binding 3 |
chr2_+_30254239 | 1.10 |
ENSMUST00000077977.14
ENSMUST00000140075.9 ENSMUST00000142801.8 ENSMUST00000100214.10 |
Miga2
|
mitoguardin 2 |
chr19_+_53665719 | 1.10 |
ENSMUST00000164202.9
|
Rbm20
|
RNA binding motif protein 20 |
chr10_+_80192293 | 1.09 |
ENSMUST00000039836.15
ENSMUST00000105351.2 |
Plk5
|
polo like kinase 5 |
chr7_+_127399789 | 1.09 |
ENSMUST00000125188.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr8_-_95405234 | 1.09 |
ENSMUST00000213043.2
|
Pllp
|
plasma membrane proteolipid |
chr9_+_108447077 | 1.07 |
ENSMUST00000019183.14
|
Dalrd3
|
DALR anticodon binding domain containing 3 |
chr4_+_138694422 | 1.07 |
ENSMUST00000116094.5
ENSMUST00000239443.2 |
Rnf186
|
ring finger protein 186 |
chr14_+_52122299 | 1.07 |
ENSMUST00000047899.13
ENSMUST00000164902.8 |
Mettl17
|
methyltransferase like 17 |
chr11_+_104122291 | 1.07 |
ENSMUST00000145227.8
|
Mapt
|
microtubule-associated protein tau |
chr9_-_107556823 | 1.06 |
ENSMUST00000010205.9
|
Gnat1
|
guanine nucleotide binding protein, alpha transducing 1 |
chr7_-_127494750 | 1.06 |
ENSMUST00000033074.8
|
Vkorc1
|
vitamin K epoxide reductase complex, subunit 1 |
chr11_+_75400889 | 1.06 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr8_+_71995554 | 1.05 |
ENSMUST00000034272.9
|
Mvb12a
|
multivesicular body subunit 12A |
chr4_+_141095415 | 1.05 |
ENSMUST00000006380.5
|
Fam131c
|
family with sequence similarity 131, member C |
chr11_+_96920956 | 1.04 |
ENSMUST00000153482.2
|
Scrn2
|
secernin 2 |
chr19_+_42024439 | 1.04 |
ENSMUST00000238137.2
ENSMUST00000026172.3 |
Ankrd2
|
ankyrin repeat domain 2 (stretch responsive muscle) |
chr2_-_160714473 | 1.04 |
ENSMUST00000103111.9
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chrX_+_100420873 | 1.03 |
ENSMUST00000052130.14
|
Gjb1
|
gap junction protein, beta 1 |
chr11_+_104122399 | 1.03 |
ENSMUST00000132977.8
ENSMUST00000132245.8 ENSMUST00000100347.11 |
Mapt
|
microtubule-associated protein tau |
chr17_+_26094466 | 1.03 |
ENSMUST00000169308.8
ENSMUST00000169085.8 |
Mettl26
|
methyltransferase like 26 |
chr15_+_31224460 | 1.01 |
ENSMUST00000044524.16
|
Dap
|
death-associated protein |
chr11_+_104122341 | 1.01 |
ENSMUST00000106993.10
|
Mapt
|
microtubule-associated protein tau |
chr9_+_114807546 | 1.01 |
ENSMUST00000183104.8
|
Osbpl10
|
oxysterol binding protein-like 10 |
chr9_+_50662625 | 1.01 |
ENSMUST00000217475.2
|
Cryab
|
crystallin, alpha B |
chr10_+_87357782 | 1.01 |
ENSMUST00000219813.2
|
Pah
|
phenylalanine hydroxylase |
chr11_-_97520511 | 1.00 |
ENSMUST00000052281.6
|
Epop
|
elongin BC and polycomb repressive complex 2 associated protein |
chr11_+_102326167 | 0.99 |
ENSMUST00000177428.2
|
Grn
|
granulin |
chr5_-_104125192 | 0.99 |
ENSMUST00000120320.8
|
Hsd17b13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
chr5_+_141227245 | 0.99 |
ENSMUST00000085774.11
|
Sdk1
|
sidekick cell adhesion molecule 1 |
chr19_+_8815024 | 0.99 |
ENSMUST00000159634.8
|
Bscl2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
chr13_-_56444118 | 0.98 |
ENSMUST00000224801.2
|
Cxcl14
|
chemokine (C-X-C motif) ligand 14 |
chr10_+_87357816 | 0.98 |
ENSMUST00000218573.2
|
Pah
|
phenylalanine hydroxylase |
chr10_+_78412783 | 0.98 |
ENSMUST00000219588.2
|
Ilvbl
|
ilvB (bacterial acetolactate synthase)-like |
chr9_+_46151994 | 0.98 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr15_-_100579450 | 0.97 |
ENSMUST00000230740.2
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr6_+_125298296 | 0.97 |
ENSMUST00000081440.14
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr7_+_112806672 | 0.97 |
ENSMUST00000047321.9
ENSMUST00000210074.2 ENSMUST00000210238.2 |
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr10_-_89342493 | 0.97 |
ENSMUST00000058126.15
ENSMUST00000105296.9 |
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr5_+_28276353 | 0.97 |
ENSMUST00000059155.11
|
Insig1
|
insulin induced gene 1 |
chr2_+_160573604 | 0.97 |
ENSMUST00000174885.2
ENSMUST00000109462.8 |
Plcg1
|
phospholipase C, gamma 1 |
chr4_+_140688514 | 0.96 |
ENSMUST00000010007.9
|
Sdhb
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr15_+_31224555 | 0.95 |
ENSMUST00000186109.2
|
Dap
|
death-associated protein |
chrX_-_7440480 | 0.95 |
ENSMUST00000115742.9
ENSMUST00000150787.8 |
Ppp1r3f
|
protein phosphatase 1, regulatory subunit 3F |
chr8_+_124380639 | 0.95 |
ENSMUST00000045487.4
|
Rhou
|
ras homolog family member U |
chr3_-_89294430 | 0.95 |
ENSMUST00000107433.8
|
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr10_+_79889322 | 0.94 |
ENSMUST00000105372.9
|
Gpx4
|
glutathione peroxidase 4 |
chr11_-_88608958 | 0.93 |
ENSMUST00000107908.2
|
Msi2
|
musashi RNA-binding protein 2 |
chr11_+_105866030 | 0.93 |
ENSMUST00000001964.8
|
Ace
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
chr10_-_108846816 | 0.93 |
ENSMUST00000105276.8
ENSMUST00000064054.14 |
Syt1
|
synaptotagmin I |
chr6_-_125290809 | 0.93 |
ENSMUST00000032489.8
|
Ltbr
|
lymphotoxin B receptor |
chr3_+_89084770 | 0.92 |
ENSMUST00000029684.15
ENSMUST00000120697.8 ENSMUST00000098941.5 |
Scamp3
|
secretory carrier membrane protein 3 |
chr19_+_41970148 | 0.92 |
ENSMUST00000026170.3
|
Ubtd1
|
ubiquitin domain containing 1 |
chr11_+_78215026 | 0.92 |
ENSMUST00000102478.4
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr14_-_30645711 | 0.92 |
ENSMUST00000006697.17
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr5_-_104125270 | 0.92 |
ENSMUST00000112803.3
|
Hsd17b13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
chr7_+_28524627 | 0.91 |
ENSMUST00000066264.13
|
Ech1
|
enoyl coenzyme A hydratase 1, peroxisomal |
chr11_+_115865756 | 0.91 |
ENSMUST00000106460.9
|
Itgb4
|
integrin beta 4 |
chr11_-_68277799 | 0.91 |
ENSMUST00000135141.2
|
Ntn1
|
netrin 1 |
chr11_-_116381125 | 0.90 |
ENSMUST00000135196.2
ENSMUST00000106391.8 |
Prpsap1
|
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
chr2_-_27136826 | 0.90 |
ENSMUST00000149733.8
|
Sardh
|
sarcosine dehydrogenase |
chr10_-_77002377 | 0.89 |
ENSMUST00000081654.13
|
Col18a1
|
collagen, type XVIII, alpha 1 |
chr7_+_127399848 | 0.89 |
ENSMUST00000139068.8
|
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr4_-_91260265 | 0.89 |
ENSMUST00000107110.8
ENSMUST00000008633.15 ENSMUST00000107118.8 |
Elavl2
|
ELAV like RNA binding protein 1 |
chr17_+_34416707 | 0.89 |
ENSMUST00000025196.9
|
Psmb8
|
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) |
chr19_+_4771089 | 0.89 |
ENSMUST00000238976.3
|
Sptbn2
|
spectrin beta, non-erythrocytic 2 |
chr7_+_44499005 | 0.89 |
ENSMUST00000150335.2
ENSMUST00000107882.8 |
Akt1s1
|
AKT1 substrate 1 (proline-rich) |
chr9_+_77824646 | 0.88 |
ENSMUST00000034904.14
|
Elovl5
|
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
chr5_-_104125226 | 0.87 |
ENSMUST00000048118.15
|
Hsd17b13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
chr5_+_137568086 | 0.87 |
ENSMUST00000198866.5
|
Tfr2
|
transferrin receptor 2 |
chr1_+_166081664 | 0.87 |
ENSMUST00000111416.7
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr7_-_132178101 | 0.86 |
ENSMUST00000084500.8
|
Oat
|
ornithine aminotransferase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:1902617 | response to fluoride(GO:1902617) |
1.3 | 4.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.1 | 5.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.1 | 3.2 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
0.9 | 3.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.9 | 2.7 | GO:0070256 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.8 | 2.5 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.7 | 2.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 2.0 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.7 | 2.0 | GO:0042853 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) oxalic acid secretion(GO:0046724) |
0.7 | 3.4 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) |
0.7 | 2.0 | GO:0006571 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.7 | 2.0 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
0.6 | 2.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.6 | 2.4 | GO:0038163 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) |
0.6 | 1.7 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.5 | 1.4 | GO:2000978 | auditory receptor cell fate determination(GO:0042668) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.5 | 4.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.4 | 1.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 2.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 2.1 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.4 | 2.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 2.5 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.4 | 2.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 1.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.4 | 1.2 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.4 | 2.8 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 2.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 3.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 2.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.4 | 8.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 1.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.4 | 3.8 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 3.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.4 | 1.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.3 | 1.7 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.3 | 1.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 2.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 10.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.0 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.3 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.3 | 0.9 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.3 | 0.9 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 2.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 1.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 1.7 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.3 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 0.8 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.3 | 1.4 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 0.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.3 | 0.8 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.3 | 0.8 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 1.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 0.8 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.3 | 1.3 | GO:0048866 | stem cell fate specification(GO:0048866) |
0.2 | 2.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.5 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 1.0 | GO:0003360 | brainstem development(GO:0003360) |
0.2 | 0.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 1.0 | GO:0038183 | histone H3-R17 methylation(GO:0034971) bile acid signaling pathway(GO:0038183) |
0.2 | 1.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.7 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.2 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 3.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 3.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 1.4 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.2 | 0.4 | GO:0072054 | renal outer medulla development(GO:0072054) |
0.2 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.1 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.2 | 1.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 0.6 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 0.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.2 | 0.6 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.4 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.2 | 0.8 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 1.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.8 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.2 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.9 | GO:0060983 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.2 | 1.1 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.2 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.2 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.2 | 0.7 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.2 | 0.5 | GO:0002658 | positive regulation of tolerance induction dependent upon immune response(GO:0002654) regulation of peripheral tolerance induction(GO:0002658) positive regulation of peripheral tolerance induction(GO:0002660) regulation of peripheral T cell tolerance induction(GO:0002849) positive regulation of peripheral T cell tolerance induction(GO:0002851) |
0.2 | 0.5 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.2 | 1.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.5 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.2 | 0.5 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 1.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.5 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 1.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 1.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 1.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 1.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.1 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 1.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 1.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.9 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.1 | 1.0 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.1 | 0.4 | GO:0001966 | thigmotaxis(GO:0001966) |
0.1 | 0.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 2.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.7 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 1.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.4 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.5 | GO:1903195 | enzyme active site formation via L-cysteine sulfinic acid(GO:0018323) primary alcohol biosynthetic process(GO:0034309) cellular response to glyoxal(GO:0036471) glycolate biosynthetic process(GO:0046295) detoxification of mercury ion(GO:0050787) negative regulation of TRAIL-activated apoptotic signaling pathway(GO:1903122) regulation of pyrroline-5-carboxylate reductase activity(GO:1903167) positive regulation of pyrroline-5-carboxylate reductase activity(GO:1903168) regulation of tyrosine 3-monooxygenase activity(GO:1903176) positive regulation of tyrosine 3-monooxygenase activity(GO:1903178) L-dopa metabolic process(GO:1903184) L-dopa biosynthetic process(GO:1903185) glyoxal metabolic process(GO:1903189) regulation of L-dopa biosynthetic process(GO:1903195) positive regulation of L-dopa biosynthetic process(GO:1903197) regulation of L-dopa decarboxylase activity(GO:1903198) positive regulation of L-dopa decarboxylase activity(GO:1903200) positive regulation of cellular amino acid biosynthetic process(GO:2000284) |
0.1 | 0.7 | GO:1905068 | positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 2.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.4 | GO:0061643 | vagus nerve morphogenesis(GO:0021644) chemorepulsion of axon(GO:0061643) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 1.4 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 1.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 2.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.5 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.9 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.6 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.8 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.5 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 1.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.1 | 0.5 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.1 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.3 | GO:0006538 | fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) glutamate catabolic process(GO:0006538) |
0.1 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.3 | GO:0021634 | optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
0.1 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.7 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.3 | GO:0061723 | glycophagy(GO:0061723) |
0.1 | 0.3 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.1 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.5 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 1.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 2.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) male mating behavior(GO:0060179) organism emergence from protective structure(GO:0071684) |
0.1 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.1 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 1.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.5 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.1 | 0.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 1.8 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.1 | 0.5 | GO:0032346 | aldosterone biosynthetic process(GO:0032342) positive regulation of aldosterone metabolic process(GO:0032346) regulation of aldosterone biosynthetic process(GO:0032347) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.1 | 1.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.3 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.3 | GO:0021750 | cerebellar molecular layer development(GO:0021679) vestibular nucleus development(GO:0021750) |
0.1 | 0.2 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 0.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 2.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 1.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.4 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.1 | 0.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 1.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 1.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 1.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.4 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.1 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 2.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 1.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.2 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.1 | 0.5 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 1.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.3 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.1 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.2 | GO:0072708 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.1 | 1.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.2 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.1 | 0.2 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 1.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 3.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 1.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.6 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 1.0 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.2 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.3 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 2.8 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:1904828 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
0.0 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.3 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.0 | 0.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 1.5 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 1.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 1.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 1.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
0.0 | 0.1 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.0 | 3.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.3 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 1.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 2.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 1.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 1.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.2 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.5 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 1.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.3 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.0 | 0.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.6 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 1.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
0.0 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.0 | 0.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.7 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
0.0 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.0 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.5 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.4 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.0 | 1.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.6 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.0 | 0.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 1.2 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0042223 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.9 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 2.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.4 | GO:0032438 | melanosome organization(GO:0032438) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 3.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:1904261 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.5 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.0 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 1.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 1.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 2.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.1 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.4 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.4 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.6 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 2.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.6 | 2.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 4.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 2.2 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.4 | 1.3 | GO:0044317 | rod spherule(GO:0044317) |
0.4 | 6.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 1.2 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.4 | 1.5 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 3.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 0.8 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 3.4 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 4.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.9 | GO:0097447 | dendritic tree(GO:0097447) |
0.2 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 1.0 | GO:0070449 | elongin complex(GO:0070449) |
0.2 | 3.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 1.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 4.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 4.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 3.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 3.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 4.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 2.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 15.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 4.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 1.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 3.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 1.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.7 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.0 | 0.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 2.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 2.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 3.5 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 3.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 3.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 7.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 4.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.1 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 1.7 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 1.6 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 4.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 9.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.7 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 3.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 1.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 1.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.1 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
1.1 | 3.2 | GO:0004001 | adenosine kinase activity(GO:0004001) |
1.0 | 2.9 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.9 | 4.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.9 | 3.6 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.8 | 2.4 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.8 | 5.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 2.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.7 | 2.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 2.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 1.7 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.5 | 2.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.5 | 2.0 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.5 | 3.8 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 2.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 2.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 1.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.4 | 1.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.4 | 2.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 2.5 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.4 | 1.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.6 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.4 | 2.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.4 | 3.2 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.4 | 2.7 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.4 | 1.1 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.4 | 5.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 1.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.3 | 7.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 10.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 1.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 2.0 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.3 | 2.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 1.3 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.3 | 0.9 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.3 | 0.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.8 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.3 | 2.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.8 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.3 | 1.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.3 | 1.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 2.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 2.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 1.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 0.7 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.2 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.6 | GO:0070540 | stearic acid binding(GO:0070540) |
0.2 | 1.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 0.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 1.0 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.2 | 1.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 2.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.7 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 1.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 3.1 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 1.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 2.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.6 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.5 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.1 | 1.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 2.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.8 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.5 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 0.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.8 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 4.3 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.3 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
0.1 | 1.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 2.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.4 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.3 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.5 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 1.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 1.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 2.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 1.6 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.1 | 0.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 12.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.8 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 1.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.6 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 1.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 1.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 1.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 6.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 2.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 1.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 1.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 9.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.5 | GO:0070008 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 1.1 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 1.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 1.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 1.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 1.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 1.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 1.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 1.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 2.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 1.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.2 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 2.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 5.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 1.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 1.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 4.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.6 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.6 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.0 | 1.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 2.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.0 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0035005 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 1.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 6.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 2.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 9.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 2.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 3.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 3.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 2.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 2.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 4.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 6.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 5.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 6.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 7.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 3.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 3.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 4.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 3.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 1.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 2.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 7.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 2.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 2.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.4 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.7 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |